Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: JAMA Psychiatry. 2016 Aug 1;73(8):804–814. doi: 10.1001/jamapsychiatry.2016.0970

Table 1.

Characteristics of Study Participants at Baseline, by Intervention and Psychiatric Comorbidity

Variable Among the Full Sample P Value Among the Subsample With Psychiatric Comorbidity P Value


LINKAGE (n = 252) Usual Care (n = 251) LINKAGE (n = 197) Usual Care (n = 198)
Demographics and socioeconomic status, No. (%)

Age group, y

 18–30 56 (22.2) 40 (15.9) .06 47 (23.9) 32 (16.2) .14


 31–45 98 (38.9) 101 (4.2) 78 (39.6) 76 (38.4)


 46–60 87 (34.5) 86 (34.3) 63 (32.0) 75 (37.9)


 ≥61 11 (4.4) 24 (9.6) 9 (4.6) 15 (7.6)

Female sex 76 (30.2) 80 (31.9) .70 67 (34.0) 75 (37.9) .44

Race/ethnicity

 African American 17 (6.7) 20 (8.0) .96 10 (5.1) 14 (7.1) .63


 Asian 16 (6.3) 18 (7.2) 14 (7.1) 9 (4.5)


 Hispanic 49 (19.4) 52 (20.7) 32 (16.2) 42 (21.2)


 Native American 6 (2.4) 4 (1.6) 4 (2.0) 3 (1.5)


 White 156 (61.9) 150 (59.8) 130 (66.0) 123 (62.1)


 Other 8 (3.2) 7 (2.8) 7 (3.6) 7 (3.5)

Education

 ≤High school graduate or GED 96 (38.1) 107 (42.6) .40 69 (35.0) 83 (41.9) .29


 Associate in arts, associate in science, or technical school 49 (19.4) 52 (20.7) 40 (20.3) 41 (20.7)


 College or higher 107 (42.5) 92 (36.7) 88 (44.7) 74 (37.4)

Annual household income ≥$50 000 140 (55.6) 138 (55.0) .90 112 (56.9) 96 (48.5) .10

Substance use, No. (%)

Any dependence

 Alcohol 170 (67.5) 159 (63.3) .33 134 (68.0) 133 (67.2) .86

 Marijuana 31 (12.3) 30 (12.0) .90 26 (13.2) 23 (11.6) .63

 Sedatives 18 (7.1) 13 (5.2) .36 17 (8.6) 12 (6.1) .33

 Heroin 12 (4.8) 8 (3.1) .37 8 (4.1) 5 (2.5) .39

 Painkillers 37 (14.7) 33 (13.1) .62 29 (14.7) 27 (13.6) .76

 Cocaine 46 (18.3) 33 (13.2) .12 35 (17.8) 27 (13.6) .26

 Amphetamines 27 (10.7) 32 (12.7) .48 24 (12.2) 23 (11.6) .86

Dependence type

 Alcohol only 107 (42.5) 118 (47.0) .12 81 (41.1) 96 (48.5) .24


 Drug only 61 (24.2) 67 (26.7) 49 (24.9) 49 (24.7)


 Alcohol and drug 63 (25.0) 41 (16.3) 53 (26.9) 37 (18.7)


 Abuse 21 (8.3) 25 (10.0) 14 (7.1) 16 (8.1)

Mental health, No. (%)

Moderate to severe depressiona 38 (15.1) 34 (13.5) .62 36 (18.3) 31 (15.7) .49

Patient activation, mean (SD)

Patient Activation Measure score, mean (SD) 65.2 (16.2) 64.3 (17.4) .56 63.9 (16.1) 64.0 (17.4) .94

Access to computer or smartphone, No. (%)

Have access 235 (93.3) 225 (89.6) .15 186 (94.4) 177 (89.4) .07

Can access the internet 237 (94.1) 232 (62.4) .47 188 (95.4) 188 (92.9) .29

Can receive email 233 (92.5) 228 (90.8) .51 185 (93.9) 183 (92.4) .56

Patient engagement in health care

Ever accessed kp.org, No. (%) 190 (75.4) 178 (70.9) .26 152 (77.2) 142 (71.7) .22

Ever talked with PCP about AOD problems at baseline, No./total No. (%)b 130/220 (59.1) 153/218 (70.2) .02 103/172 (59.9) 132/173 (76.3) .001

Abbreviations: AOD, alcohol and other drug; GED, General Education Development; PCP, primary care physician.

a

Nine-item Patient Health Questionnaire score of at least 15.

b

The question was asked only among those who had a Kaiser Permanente health care professional whom the patient considered to be his or her regular or personal physician or nurse practitioner.